Monitoring response and resistance to EGFR inhibition with circulating tumor DNA in a non-small cell lung cancer patient-derived xenograft

被引：0
作者：
Do, Long H.
Pippa, Raffaella
Andrews, Warren
Chien, Yuan
Sperry, Jantzen
Nakashima, Jonathan
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-6690
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6690
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Analysis of sensitivity of genomic signatures of therapeutic responses of non-small cell lung cancer in patient-derived xenograft models
    Tavassoly, Iman
    Iyengar, Ravi
    CANCER RESEARCH, 2018, 78 (13)
  • [22] Role of Circulating Tumor DNA Profiling in Patients with Non-Small Cell Lung Cancer Treated with EGFR Inhibitor
    Ku, Bo Mi
    Kim, Yeon Jeong
    Park, Donghyun
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    Sun, Jong-Mu
    ONCOLOGY, 2022, 100 (04) : 228 - 237
  • [23] CIRCULATING TUMOR DNA ANALYSIS IN PATIENT-DERIVED XENOGRAFT MODELS OF GLIOBLASTOMA
    Perdigones, Nieves
    Connor, Sydney
    Hartman, Lauren
    Contente-Cuomo, Tania
    Reid, George
    Markus, Havell
    Berens, Michael
    Dhruv, Harshil
    Murtaza, Muhammed
    NEURO-ONCOLOGY, 2017, 19 : 101 - 101
  • [24] Activity of SGN-B6A in patient-derived xenograft models of non-small cell lung cancer.
    Lyon, Robert P.
    Gosink, John J.
    Hale, Christopher J.
    Stilwell, Jackie L.
    Allred, Sean
    Hensley, Kelly M.
    Kumar, Vineet
    Patilea-Vrana, Gabby
    Nazarenko, Natalya
    CANCER RESEARCH, 2021, 81 (13)
  • [25] Circulating Tumor DNA as a Biomarker in Oligometastatic Non-small Cell Lung Cancer
    Lebow, E. S.
    Murciano-Goroff, Y.
    Razavi, P.
    Reis-Filho, J. S.
    Flynn, J.
    Zhang, Z.
    Tu, H. Y.
    Bertucci, C.
    Lim, L. P.
    Li, M.
    Drilon, A.
    Riely, G.
    Rudin, C. M.
    Jones, D.
    Yang, T. J.
    Rimner, A.
    Arcila, M. E.
    Isbell, J.
    Li, B. T.
    Gomez, D. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S174 - S174
  • [26] Application of Circulating Tumor DNA as a Biomarker for Non-Small Cell Lung Cancer
    Yang, Jialiang
    Hui, Yan
    Zhang, Yanxiang
    Zhang, Minghui
    Ji, Binbin
    Tian, Geng
    Guo, Yangqiang
    Tang, Min
    Li, Lianxing
    Guo, Bella
    Ma, Tonghui
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [27] The establishment of patient-derived organoid models and drug response of resectable non-small cell lung cancer
    Chen, J-H.
    Chu, X-P.
    Zhang, J-T.
    Nie, Q.
    Su, J.
    Yan, H-H.
    Zheng, H-P.
    Chen, X.
    Song, M-M.
    Chang, L-P.
    Li, P-S.
    Guan, Y-F.
    Wu, Y-L.
    Zhong, W-Z.
    ANNALS OF ONCOLOGY, 2019, 30
  • [28] Circulating Tumor DNA for Mutation Detection and Identification of Mechanisms of Resistance in Non-Small Cell Lung Cancer
    Yeung, Kay T.
    More, Soham
    Woodward, Brian
    Velculescu, Victor
    Husain, Hatim
    MOLECULAR DIAGNOSIS & THERAPY, 2017, 21 (04) : 375 - 384
  • [29] Multi-region patient-derived xenograft models from non-small cell lung cancer patients enrolled in lung TRACERx
    Hynds, Robert E.
    Pearce, David R.
    Akarca, Ayse U.
    Ward, Sophia
    Huebner, Ariana
    Pich, Oriol
    Wilson, Gareth A.
    Gowers, Kate H.
    Towns, Rebecca
    Ben Aissa, Assma
    Veeriah, Selvaraju
    Quezada, Sergio A.
    Jamal-Hanjani, Mariam
    Janes, Sam M.
    McGranahan, Nicholas
    Moore, David A.
    Marafioti, Teresa
    Swanton, Charles
    CANCER RESEARCH, 2022, 82 (12)
  • [30] Patient-derived Xenograft Models of Small Cell Lung Cancer for Therapeutic Development
    Vidhyasagar, V.
    Ul Haq, S.
    Lok, B. H.
    CLINICAL ONCOLOGY, 2020, 32 (10) : 619 - 625
12345